Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NAGE

Niagen Bioscience, Inc.

CIK 0001386570 · Nasdaq

NasdaqHealth CareMedicinal Chemicals & Botanical Products
$3.21
↑ 0.06 (1.90%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$253.99M
P/E Ratio
15.88
EPS
0.22
Dividend Yield
Not covered
52W Position
4%
Beta
1.25

Valuation multiples

Fwd P/E
21.55
PEG
Not covered
P/B
3.08
P/S
1.97
EV/Revenue
1.97
ROE
19.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 4%
$2.87$10.52

Latest Financials

2025-12-31 FY
Revenue
$129.42M
Net Income
$17.38M
Total Assets
$106.41M
Free Cash Flow
–

Recent news